Gene Delivery Using Chemical Methods - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 189

[106] Nguyen HK, Lemieux P, Vinogradov SV, Gebhart CL, Guerin N, Paradis G, et al.
Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents.
Gene Ther 2000;7:126-38.
[107] Ochietti B, Lemieux P, Kabanov AV, Vinogradov S, St-Pierre Y, Alakhov V. Inducing
neutrophil recruitment in the liver of IC AM-1-deficient mice using polyethyleneimine
grafted with Pluronic ® P123 as an organ-specific carrier for transgenic ICAM-1. Gene
Ther 2002;9:939-45.
[108] Ochietti B, Guerin N, Vinogradov SV, St-Pierre Y, Lemieux P, Kabanov AV, et al.
Altered organ accumulation of oligonucleotides using polyethyleneimine grafted with
poly (ethylene oxide) or pluronic ® as carriers. J Drug Target 2002;10:113-21.
[109] Melik-Nubarov NS, Pomaz OO, Dorodnych T, Badun GA, Ksenofontov AL,
Schemchukova OB, et al. Interaction of tumor and normal blood cells with ethylene
oxide and propylene oxide block copolymers. FEBS Lett 1999;446:194-8.
[110] Lemieux P, Guerin N, Paradis G, Proulx R, Chistyakova L, Kabanov A, et al. A com-
bination of poloxamers increases gene expression of plasmid DNA in skeletal muscle.
Gene Ther 2000;7:986-91.
[111] Hedley ML. Formulations containing poly (lactide- co -glycolide) and plasmid DNA
expression vectors. Expert Opin Biol Ther 2003;3:903-10.
[112] Luten J, van Nostrum CF, De Smedt SC, Hennink WE. Biodegradable polymers as non-
viral carriers for plasmid DNA delivery. J Control Release 2008;126:97-110.
[113] Walter E, Moelling K, Pavlovic J, Merkle HP. Microencapsulation of DNA using poly
(D,L-lactide- co -glycolide): stability issues and release characteristics. J Control Release
1999;61:361-74.
[114] Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in inject-
able poly (lactide- co -glycolide). Nat Biotechnol 2000;18:52-7.
[115] Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH. Poly (D,L-lactide- co -glycolide)-
encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded
protein after oral administration. Vaccine 1997;15:814-17.
[116] Oster CG, Kissel T. Comparative study of DNA encapsulation into PLGA mic-
roparticles using modified double emulsion methods and spray drying techniques.
J Microencapsulation 2005;22:235-44.
[117] Diez S, Tros de Ilarduya C. Versatility of biodegradable poly (D,L-lactic- co -glycolic
acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 2006;63:188-97.
[118] Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SB, Farrar GH. Formulation of poly
(D,L-lactic- co -glycolic acid) microparticles for rapid plasmid DNA delivery. J Control
Release 2000;66:229-41.
[119] Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ. Poly (lactic acid)-
poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
J Control Release 2001;75:221-4.
[120] Hsu YY, Hao T, Hedley ML. Comparisons of process parameters for microencapsula-
tion of plasmid DNA in poly (D,L-lactic- co -glycolic) acid microspheres. J Drug Target
1999;7:313-23.
[121] Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Influence of formula-
tion parameters on the characteristics of poly (D,L-lactide- co -glycolide) micro-
spheres containing poly (L-lysine) complexed plasmid DNA. J Control Release 1999;
60:279-86.
[122] Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Preparation and character-
ization of poly (D,L-lactide- co -glycolide) microspheres for controlled release of poly
(L-lysine) complexed plasmid DNA. Pharm Res 1999;16:509-13.